Skip to content

Virtual Reality-Based Exercise in Cancer Patients

Virtual Reality-Based Exercise in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02165163
Enrollment
20
Registered
2014-06-17
Start date
2013-09-30
Completion date
2014-08-31
Last updated
2015-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distorted; Balance, Motor Deficit

Brief summary

The aim of the present study is to evaluate an innovative virtual reality-based balance training intervention for improving clinically relevant motor performances (balance and gait) in cancer patients. The investigators hypothesize that the virtual reality-based balance training intervention will improve balance and gait performances in cancer patients compared to a control group receiving usual care only.

Interventions

OTHERBalance Training

Balance training will be conducted individually two times per week for 4 weeks. Each training session will include virtual reality tasks such as ankle reaching and obstacle crossing using a virtual obstacle shown on a computer screen. Each session will last 30 - 45 minutes.

Sponsors

University of Arizona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* ability to ambulate without assistance * willingness to provide informed consent * cancer * neuropathy related to chemotherapy

Exclusion criteria

* severe neurologic, cardiovascular, metabolic, or psychiatric disorders * severe visual impairment * cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Postural Balanceafter 4 weeksPostural Balance during quiet standing for 30 seconds will be assessed using validated wearable sensor technologies (BalanSens™)

Secondary

MeasureTime frameDescription
Gait performance4 weeksGait performance will be measured using validated wearable sensor technology (LEGSys™)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026